Cambridge Consultants will be speaking and exhibiting virtually at SLAS Digital International Conference and Exhibition 2021.

The Society for Laboratory Automation and Screening (SLAS) conference is the premier conference and industry exhibition dedicated to uniting a global community focused on advancing scientific discovery and technology. The three-day conference and exhibition consists of a program of virtual presentations with live Q&A sessions and an engaging gallery of E-posters.

Join the event

CellPreserve: A platform to enable longitudinal cell studies

Date | 26 January 2021
Time | 10:57am - 11:22am EST
Speaker | Josh Gibson, Senior Physicist, Physics and Sensors, Cambridge Consultants

We present an innovative apparatus and method for extending the lifetime of isolated rare cells to weeks rather than typical lifetimes of about 24 hours. This opens up a range of new and novel analysis techniques by providing a method for longitudinal studies of rare cells with applications in drug discovery and in-line QC for immunotherapy manufacturing.

Related Content

이벤트 보기

Octane Ophthalmology Tech Forum 2023
패널 토론스폰서

Octane | Ophthalmology Tech Forum 2023

2023년 06월 8일 - 2023년 06월 9일
Balboa Bay Resort in Newport Beach, CA, Newport beach, CA

Join the conversation and take part in the cutting edge of ophthalmic innovation at Octane’s Ophthalmology Tech Forum.

Ai Summit London 2023
스피커스폰서

AI Summit 2023

2023년 06월 14일 - 2023년 06월 15일
Tobacco Docks, London

AI Summit은 비즈니스 생산성의 변혁을 불러일으킬 AI가 실제 기업 조직에 미칠 영향을 살펴볼 수 있는 세계 최초이자 최대 규모의 컨퍼런스 전시회입니다.

fbif summary
스피커스폰서

Clone of AI Summit Seoul 2022

2022년 12월 7일 - 2022년 12월 8일
Coex, Grand Ballroom, Seoul, Korea

AI Summit Seoul에서는 AI의 비즈니스 영향에 초점을 맞추어 전략, 구현 및 활용 사례를 다룹니다.

The 22nd annual Medtech MVP conference
패널 토론

The 22nd annual Medtech MVP conference

2023년 06월 20일 - 2023년 06월 21일
Four Seasons Hotel, Minneapolis, MN.

The Medtech MVP conference gathers leading innovators, investors and executives from around the world, to discuss issues such as reducing the cost of care, overcoming valuation overhang and the implications of raising capital and exits, expansion of big tech into healthcare and medtech, leveraging DEI to build high-performance executive teams.